ALNY vs. HCA: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALNY and HCA, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
HCA’s market capitalization of 89.30 billion USD is significantly greater than ALNY’s 40.16 billion USD, highlighting its more substantial market valuation.
HCA carries a higher beta at 1.50, indicating it’s more sensitive to market moves, while ALNY (beta: 0.21) exhibits greater stability.
Symbol | ALNY | HCA |
---|---|---|
Company Name | Alnylam Pharmaceuticals, Inc. | HCA Healthcare, Inc. |
Country | US | US |
Sector | Healthcare | Healthcare |
Industry | Biotechnology | Medical - Care Facilities |
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. | Mr. Samuel N. Hazen |
Price | 307.99 USD | 371.18 USD |
Market Cap | 40.16 billion USD | 89.30 billion USD |
Beta | 0.21 | 1.50 |
Exchange | NASDAQ | NYSE |
IPO Date | June 1, 2004 | March 10, 2011 |
ADR | No | No |
Performance Comparison
This chart compares the performance of ALNY and HCA over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
This section compares the market valuation of ALNY and HCA. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.
- ALNY’s Price-to-Earnings (P/E) ratio of -148.09 is negative, highlighting a lack of current profitability. This situation is a concern for its immediate financial performance and can impact investor confidence.
- ALNY’s Price-to-Book (P/B) ratio of 345.99 is very high, indicating that investors are willing to pay a substantial premium over its accounting net asset value. HCA, with a P/B ratio of -26.31, shows a negative book value, which is a critical concern for its financial solvency.
Symbol | ALNY | HCA |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | -148.09 | 16.02 |
Forward PEG Ratio (TTM) | -40.17 | 1.20 |
Price-to-Sales Ratio (P/S, TTM) | 17.10 | 1.25 |
Price-to-Book Ratio (P/B, TTM) | 345.99 | -26.31 |
EV-to-EBITDA (TTM) | -264.89 | 9.58 |
EV-to-Sales (TTM) | 17.22 | 1.88 |
Dividend Comparison
ALNY currently offers no dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while HCA provides a 0.55% dividend yield, offering investors a component of income return.
Symbol | ALNY | HCA |
---|---|---|
Dividend Yield (TTM) | 0.00% | 0.55% |
Financial Strength Metrics Comparison
This section evaluates the financial strength of ALNY and HCA. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.
- ALNY’s Debt-to-Equity (D/E) ratio of 11.28 is very high, signifying a heavy reliance on debt and a high degree of financial leverage. HCA’s D/E ratio of -13.20 reflects negative shareholder equity, a severe condition that undermines its financial foundation.
- ALNY’s Interest Coverage Ratio (ICR) of -0.79 is negative. This implies its operating earnings are insufficient to meet its interest expenses, a serious situation that threatens its financial stability and capacity to honor debt commitments.
Symbol | ALNY | HCA |
---|---|---|
Current Ratio (TTM) | 3.04 | 1.19 |
Quick Ratio (TTM) | 2.98 | 1.06 |
Debt-to-Equity Ratio (TTM) | 11.28 | -13.20 |
Debt-to-Asset Ratio (TTM) | 0.31 | 0.78 |
Net Debt-to-EBITDA Ratio (TTM) | -1.85 | 3.23 |
Interest Coverage Ratio (TTM) | -0.79 | 5.17 |